A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

NCT ID: NCT04552899

Last Updated: 2024-04-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

665 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-19

Study Completion Date

2023-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This phase III study will evaluate the efficacy, safety and pharmacokinetics (PK) of recombinant human pentraxin-2 (rhPTX-2; PRM-151) zinpentraxin alfa, compared with placebo in participants with idiopathic pulmonary fibrosis (IPF).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Idiopathic Pulmonary Fibrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Zinpentraxin Alfa

Participants will receive intravenous (IV) infusions of Zinpentraxin Alfa over 50-70 minutes on Days 1, 3 and 5, then followed by infusions every 4 weeks (Q4W) to Week 48.

Group Type EXPERIMENTAL

PRM-151 (Zinpentraxin Alfa)

Intervention Type DRUG

A 10 mg/kg IV infusion of PRM-151 based on the participants weight will be administered on Days 1, 3 and 5 followed by infusions Q4W to Week 48.

Placebo

Participants will receive IV infusions of placebo over 50-70 minutes on Days 1, 3 and 5, followed by infusions Q4W to Week 48.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Placebo matching PRM-151 will be administered by IV infusion on Days 1, 3 and 5, followed by infusions Q4W to Week 48.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PRM-151 (Zinpentraxin Alfa)

A 10 mg/kg IV infusion of PRM-151 based on the participants weight will be administered on Days 1, 3 and 5 followed by infusions Q4W to Week 48.

Intervention Type DRUG

Placebo

Placebo matching PRM-151 will be administered by IV infusion on Days 1, 3 and 5, followed by infusions Q4W to Week 48.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Documented diagnosis of IPF per the 2018 American Thoracic Society (ATS)/European Respiratory Society (ERS)/Japanese Respiratory Society (JRS)/Latin American Thoracic Society (ALAT) Clinical Practice Guideline
* High-resolution computed tomography (HRCT) pattern consistent with the diagnosis of IPF, confirmed by central review of Chest HRCT and central review of any available lung biopsy (LB)
* Minimum 6 minute walk distance (6MWD) of 150 meters with maximum use of 6 L/min at sea-level and up-to 8 L/min at altitude of supplemental oxygen while maintaining oxygen saturation of greater than or equal to (\>/= )83% during the 6 minute walk test (6MWT) during screening
* FVC \>/= 45% predicted during screening as determined by the over-reader
* Forced expiratory volume in 1 second (FEV1)/FVC ratio greater than (\>) 0.70 during screening determined by the over-reader
* Diffusing capacity for carbon monoxide (DLCO) \>/= 30% and less than or equal to (\</=) 90% of predicted at screening as determined by the over-reader
* If receiving pirfenidone or nintedanib treatment for IPF, the participant must have been on treatment for at least 3 months and a stable dose for at least 4 weeks prior to screening, and during screening
* If not currently receiving nintedanib or pirfenidone treatment (either treatment naïve or having previously taken and discontinued) must have discontinued such treatment \>/= 4 weeks prior to screening and during screening
* Anticipated life expectancy of at least 12 months at baseline
* Participant and investigator considered all medicinal treatment options and/or possibly lung transplantation prior to considering participation in the study.
* For women of childbearing potential (excluding participant enrolling in Japan): agreement to remain abstinent or use contraception
* For men: agreement to remain abstinent or use a condom, and agreement to refrain from donating sperm
* Anticipated life expectancy of at least 12 months at baseline, according to the investigator's judgment
* For participant enrolled in the extended China enrollment phase: current resident of mainland China, Hong Kong, or Taiwan, and of Chinese ancestry

Exclusion Criteria

* Evidence of other known causes of Interstitial Lung Disease (ILD)
* FVC% predicted value showing repeated increase in the 6 months period prior to screening and including screening value
* Emphysema present on greater than or equal to (\>/=) 50% of the HRCT, or the extent of emphysema is greater than the extent of fibrosis, according to central review of the HRCT
* Receiving nintedanib in combination with pirfenidone
* Received cytotoxic, immunosuppressive, cytokine modulating, or receptor antagonist agents (including but not limited to methotrexate, azathioprine, mycophenolate mofetil, cyclophosphamide, cyclosporine or other steroid sparing agent) within 4 weeks prior to or during screening
* Receiving systemic corticosteroids equivalent to prednisone \> 10 mg/day or equivalent within 2 weeks prior to or during screening
* Acute respiratory or systemic bacterial, viral, or fungal infection either during screening or prior to screening and not successfully resolved 4 weeks prior to screening visit
* Participants with active or latent tuberculosis (confirmed within the 6 months prior to or during screening, by a positive screening test \[interferon gamma release assay\])
* Resting oxygen saturation of \< 89% using up to 4 L/min of supplemental oxygen at sea level and up to 6 L/min at altitude (\>/= 5000 feet \[1524 meters\] above sea level) during screening
* Class IV New York Heart Association chronic heart failure
* Historical evidence of left ventricular ejection fraction \< 35%
* Presence of pulmonary hypertension that, in the investigator's opinion, would substantially limit the ability to comply with study requirements or may influence any of the safety or efficacy assessments included in the study
* Cardiopulmonary rehabilitation program based on exercise training that has been completed within 8 weeks prior to screening or planned to start during the participant enrollment in this trial
* History of smoking, alcohol or substance abuse disorder, or a malignancy
* Previous treatment with PRM-151
* Clinically significant abnormality on ECG during screening that, in the opinion of the investigator, may pose an additional risk in administering study drug to the participant including prolonged corrected QT interval \> 450 ms (for men) or \> 470 ms (for women) on ECG during screening based on the Fridericia correction formula
* Clinically significant laboratory test abnormalities during screening (hematology, serum chemistry, and urinalysis) that, in the opinion of the investigator, may pose an additional risk in administering study drug to the participant
* Pregnant or breastfeeding, or become pregnant during the study or within 8 weeks after the final dose of PRM-151
* Women of childbearing potential (Only for participants enrolling in Japan)
Minimum Eligible Age

40 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

Banner University Medical Center Phoenix; Main Pharmacy

Phoenix, Arizona, United States

Site Status

Lovelace Scientific Resources, Inc.

Phoenix, Arizona, United States

Site Status

UC Irvine Medical Center

Orange, California, United States

Site Status

Stanford Hospital and Clinics

Palo Alto, California, United States

Site Status

University of California Davis

Sacramento, California, United States

Site Status

Inst. of Healthcare Assessment, Inc.

San Diego, California, United States

Site Status

UCSF Medical Center

San Francisco, California, United States

Site Status

Paloma Medical Group

San Juan Capistrano, California, United States

Site Status

William Sansum Diabetes Center

Santa Barbara, California, United States

Site Status

University of Colorado - Anschutz Medical Campus (University of Colorado Health Sciences Center)

Aurora, Colorado, United States

Site Status

National Jewish Health Medical Center

Denver, Colorado, United States

Site Status

Yale New Haven Hospital

New Haven, Connecticut, United States

Site Status

Georgetown University Medical Center

Washington D.C., District of Columbia, United States

Site Status

Meris Clinical Research

Brandon, Florida, United States

Site Status

Florida Lung, Asthma and Sleep Specialists (FLASS) - Celebration

Celebration, Florida, United States

Site Status

Advanced Pulmonary & Sleep Research Institute of Florida

Daytona Beach, Florida, United States

Site Status

University of Florida Division of Pulmonary, Critical Care, and Sleep Medicine

Gainesville, Florida, United States

Site Status

Malcom Randall VA Medical Center

Gainesville, Florida, United States

Site Status

University of Florida Health Pulmonology - Jacksonville

Jacksonville, Florida, United States

Site Status

Advanced Pulmonary Research Institute

Loxahatchee Groves, Florida, United States

Site Status

San Marcus Research Clinic Inc.

Miami, Florida, United States

Site Status

Renstar Medical Research

Ocala, Florida, United States

Site Status

Central Florida Pulmonary Group, PA

Orlando, Florida, United States

Site Status

Sarasota Memorial Health Care System; Cancer Research Program

Sarasota, Florida, United States

Site Status

University of South Florida

Tampa, Florida, United States

Site Status

Integral ? Clinical Trial Solutions

Weston, Florida, United States

Site Status

Clinical Site Partners Orlando

Winter Park, Florida, United States

Site Status

Emory University

Atlanta, Georgia, United States

Site Status

Piedmont Healthcare Pulmonary and Critical Care Research

Austell, Georgia, United States

Site Status

NorthShore University HealthSystem

Evanston, Illinois, United States

Site Status

Indiana Univ School of Med

Indianapolis, Indiana, United States

Site Status

University of Iowa Hospitals and Clinics; Investigational Drug Services

Iowa City, Iowa, United States

Site Status

University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status

University of Louisville Health Sciences Center

Louisville, Kentucky, United States

Site Status

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

Brigham & Women'S Hospital

Boston, Massachusetts, United States

Site Status

Covenant Medical Center - Cooper

Saginaw, Michigan, United States

Site Status

University of Minnesota Medical Center

Minneapolis, Minnesota, United States

Site Status

Mayo Clinic Rochester

Rochester, Minnesota, United States

Site Status

The Lung Research Center

Chesterfield, Missouri, United States

Site Status

Washington University

St Louis, Missouri, United States

Site Status

University of Nebraska Medical Center

Omaha, Nebraska, United States

Site Status

Pulmonary & Allergy Associates

Summit, New Jersey, United States

Site Status

Lenox Hill Hospital

New York, New York, United States

Site Status

American Health Research Inc.

Charlotte, North Carolina, United States

Site Status

Duke University Medical Center

Durham, North Carolina, United States

Site Status

Pulmonix Research

Greensboro, North Carolina, United States

Site Status

PMG Research of Wilmington

Wilmington, North Carolina, United States

Site Status

University of Cincinnati Cancer Institute

Cincinnati, Ohio, United States

Site Status

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Site Status

Mercy St. Vincent Medical Center

Toledo, Ohio, United States

Site Status

Oregon Health and Science University

Portland, Oregon, United States

Site Status

Jefferson University Physicians (JUP) - Jefferson Pulmonary

Philadelphia, Pennsylvania, United States

Site Status

Temple University Medical Center

Philadelphia, Pennsylvania, United States

Site Status

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Site Status

Medical University of South Carolina Hospital

Charleston, South Carolina, United States

Site Status

SleepMed of South Carolina

Columbia, South Carolina, United States

Site Status

Lowcountry Lung and Critical Care

North Charleston, South Carolina, United States

Site Status

Spartanburg Medical Center

Spartanburg, South Carolina, United States

Site Status

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

Horizon Clinical Research Group

Cypress, Texas, United States

Site Status

Cardiopulmonary Research Science and Technology Institute

Dallas, Texas, United States

Site Status

University of Texas Southwestern Medical Center; Heart and Lung Clinic

Dallas, Texas, United States

Site Status

University of Texas Medical Branch; Cardiology Department

Galveston, Texas, United States

Site Status

DCOL Center for Clinical Research

Longview, Texas, United States

Site Status

Metroplex Pulmonology & Sleep Center

McKinney, Texas, United States

Site Status

Audie L. Murphy VA Hospital, STVHCS

San Antonio, Texas, United States

Site Status

University Of Utah Hosp & Clin; Investigational Pharmacy

Salt Lake City, Utah, United States

Site Status

Inova Fairfax Hospital/IHVI; Cardiology

Falls Church, Virginia, United States

Site Status

Virginia Commonwealth University

Richmond, Virginia, United States

Site Status

University of Wisconsin-Madison

Madison, Wisconsin, United States

Site Status

Hospital Britanico de Buenos Aires

Ciudad Autonoma Buenos Aires, , Argentina

Site Status

Fundacion Respirar (Centro Medico Dra. De Salvo)

Ciudad Autonoma Buenos Aires, , Argentina

Site Status

Instituto de Medicina Respiratoria, IMeR; Clinic/Outpatient Facility

Córdoba, , Argentina

Site Status

Centro Medico de Enfermedades Respiratorias (CEMER)

Florida, Buenos Aires, , Argentina

Site Status

Centro de estudios respiratorios

Mar del Plata, , Argentina

Site Status

Fundacion Scherbovsky

Mendoza, , Argentina

Site Status

INSARES

Mendoza, Mendoza City, , Argentina

Site Status

Investigaciones en Patologias Respiratorias

San Miguel de Tucumán, , Argentina

Site Status

Royal Prince Alfred Hospital

Camperdown, New South Wales, Australia

Site Status

Cairns Base Hospital; Cancer Care Centre

Cairns, Queensland, Australia

Site Status

Lung Research Queensland

Nundah, Queensland, Australia

Site Status

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia

Site Status

The Queen Elizabeth Hospital

Adelaide, South Australia, Australia

Site Status

Austin Hospital; Cancer Clinical Trials Centre

Melbourne, Victoria, Australia

Site Status

Monash Medical Centre; Medicine

Melbourne, Victoria, Australia

Site Status

The Alfred Hospital

Prahan, Victoria, Australia

Site Status

Fiona Stanley Hospital

Murdoch, Western Australia, Australia

Site Status

Klinikum Klagenfurt am Wörthersee; 2. Medizinische Abteilung

Klagenfurt, , Austria

Site Status

Landeskrankenhaus Salzburg; Gynäkologie Und Onkologie

Salzburg, , Austria

Site Status

ULB Hôpital Erasme

Brussels, , Belgium

Site Status

Cliniques Universitaires Saint-Luc; Pharmacy

Brussels, , Belgium

Site Status

UZ Leuven

Leuven, , Belgium

Site Status

C. H. U. Sart-Tilman; Laboratory

Liège, , Belgium

Site Status

CHU UCL Namur / site Godinne

Yvoir, , Belgium

Site Status

Hospital das Clinicas - UFMG

Belo Horizonte, Minas Gerais, Brazil

Site Status

Santa Casa de Misericordia de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

University of Alberta Hospital

Edmonton, Alberta, Canada

Site Status

Synergy Respiratory Care

Sherwood Park, Alberta, Canada

Site Status

Kelowna Respiratory and Allergy Clinic

Kelowna, British Columbia, Canada

Site Status

Vancouver General Hospital; Gordon and Leslie Diamond Health Care

Vancouver, British Columbia, Canada

Site Status

Eastern Health - General Hospital

St. John's, Newfoundland and Labrador, Canada

Site Status

The Rhema Research Institute

Owen Sound, Ontario, Canada

Site Status

Dr. Syed Anees Medicine Profession Corporation

Windsor, Ontario, Canada

Site Status

Centre Hospitalier de l'Universite de Montreal - Notre - Dame Hos pital

Montreal, Quebec, Canada

Site Status

McGill University, Montreal Chest Institute; Viral and other Infectious

Montreal, Quebec, Canada

Site Status

C.I.C. Mauricie

Trois-Rivières, Quebec, Canada

Site Status

CMU-Beijing Chao-Yang Hospital-Beijing Institute of Respiratory Medicine

Beijing, , China

Site Status

China-Japan Friendship Hospital

Beijing, , China

Site Status

Beijing Friendship Hospital Affiliated of Capital University of Medical Science

Beijing, , China

Site Status

Peking University Third Hospital

Beijing, , China

Site Status

Peking Union Medical College Hospital; Pharmacy

Beijing, , China

Site Status

Xiangya Hospital Central South University

Changsha, , China

Site Status

The Second Xiangya Hospital of Central South University

Changsha, , China

Site Status

The Third Xiangya Hospital Of Central South University

Changsha, , China

Site Status

West China Hospital, Sichuan University

Chengdu, , China

Site Status

Southern Medical University Nanfang Hospital

Guangdong Province Guangzhou City, , China

Site Status

The First Affilicated Hospital, Sun Yat-sen University

Guangzhou, , China

Site Status

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, , China

Site Status

1st Affiliated Hospital of Zhejiang University; Clinical Trial Pharmacy

Hangzhou, , China

Site Status

Inner Mongolia Autonomous Region People's Hospital

Hohhot, , China

Site Status

Qilu Hospital of Shandong University

Jinan, , China

Site Status

The 1st Affiliated Hospital of Nanchang Unversity

Nanchang, , China

Site Status

Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School

Nanjing, , China

Site Status

Ningbo First Hospital

Ningbo, , China

Site Status

Ruijin Hospital Shanghai Jiaotong University School of Medicine

Shanghai, , China

Site Status

Huadong Hospital Affiliated to Fudan University

Shanghai, , China

Site Status

Shanghai Pulmonary Hospital

Shanghai, , China

Site Status

China Medical University (CMU) First Affiliated Hospital

Shenyang, , China

Site Status

Shengjing Hospital of China Medical University

Shenyang, , China

Site Status

Hebei Medical University - The Second Hospital

Shijiazhuang, , China

Site Status

Tianjin Medical University General Hospital

Tianjin, , China

Site Status

Tongji Hospital Tongji Medical College Huazhong University of Science and Technology

Wuhan, , China

Site Status

Wuxi People's Hospital

Wuxi, , China

Site Status

Tangdu Hospital, The Fourth Military Medical University; Neurology Department

Xi'an, , China

Site Status

Qinghai Provincial People?s Hospital

Xining, , China

Site Status

Henan University of Traditional Chinese Medicine (HUTCM) The First Affiliated Hospital

Zhengzhou, , China

Site Status

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, , China

Site Status

Fakultní Nemocnice Brno

Brno, , Czechia

Site Status

Fakultni nemocnice Olomouc

Olomouc, , Czechia

Site Status

Fakultni Nemocnice Plzen - Klinika Pneumologie a Ftizeologie

Pilsen, , Czechia

Site Status

Thomayerova nemocnice; Lekarna - pavilon H

Prague, , Czechia

Site Status

Nemocnice Na Bulovce

Prague, , Czechia

Site Status

Krajská nemocnice T. Bati, a. s.

Zlín, , Czechia

Site Status

Aarhus Universitetshospital Skejby

Aarthus N, , Denmark

Site Status

Gentofte Hospital

Hellerup, , Denmark

Site Status

Odense Universitetshospital

Odense C, , Denmark

Site Status

Turku University Hospital

Turku, , Finland

Site Status

Hopital Avicenne

Bobigny, , France

Site Status

Centre Hospitalier Regional Universitaire de Brest - Hopital de la Cavale Blanche

Brest, , France

Site Status

Hopital Louis Pradel

Bron, , France

Site Status

Hospital d Instructions des Armees Percy

Clamart, , France

Site Status

CHU Dijon Bourgogne Hôpital François Mitterand

Dijon, , France

Site Status

CHU de Grenoble - Hôpital André Michallon; Pole Pharmacie

La Tronche, , France

Site Status

Centre Hospitalier Regional Universitaire de Lille

Lille, , France

Site Status

Servie de Pneumologie et centre de Transplantation Pulmonaire

Marseille, , France

Site Status

CHU de Montpellier Hopital Arnaud de Villeneuve; de Génétique

Montpellier, , France

Site Status

CHU Nice - Hôpital Pasteur 2

Nice, , France

Site Status

Hopital Bichat Claude Bernard; CIC

Paris, , France

Site Status

European Hospital Georges Pompidou (HEGP)

Paris, , France

Site Status

Hopital Haut Leveque

Pessac, , France

Site Status

Centre Hospitalier Universitaire de Reims; l'Hopital Maison Blanche

Reims, , France

Site Status

CHU de Rennes - Hopital de Pontchaillo

Rennes, , France

Site Status

CHU Tours - Hôpital Bretonneau; Pharmacie

Tours, , France

Site Status

Zentralklinik Bad Berka GmbH; Pneumologie

Bad Berka, , Germany

Site Status

Evang. Lungenklinik Berlin Klinik für Pneumologie

Berlin, , Germany

Site Status

Universitatsklinikum Essen; Innere Klinik

Essen, , Germany

Site Status

IFS - Interdisziplinäres Facharztzentrum; Institut für klinische Forschung Pneumologie

Frankfurt am Main, , Germany

Site Status

Universitatsklinikum Gießen und Marburg GmbH

Giessen, , Germany

Site Status

Medizinische Hochschule Hannover; Zentrum Innere Medizin - Klinik fur Pneumologie

Hanover, , Germany

Site Status

Thoraxklinik-Heidelberg gGmbH; Apotheke der Thoraxklinik

Heidelberg, , Germany

Site Status

Universitätsklinikum des Saarlandes; Klinik für Augenheilkunde

Homburg/Saar, , Germany

Site Status

Lungenfachklinik Immenhausen

Immenhausen, , Germany

Site Status

Universitatsklinikum Leipzig; Apotheke

Leipzig, , Germany

Site Status

IKF Pneumologie Mainz Helix Medical Excellence Center Mainz

Mainz, , Germany

Site Status

Praxis für Pneumologie Dr. Silke Mronga & Dr. Lukas Jerrentrup

Marburg, , Germany

Site Status

Lungenklinik Münnerstadt, Thoraxzentrum Bezirk Unterfranken

Münnerstadt, , Germany

Site Status

Krankenhaus Bethanien gGmbH

Solingen, , Germany

Site Status

Evangelismos Hospital; Department of Critical Care and Pulmonary Services

Athens, , Greece

Site Status

Attikon University General Hospital

Chaïdári, , Greece

Site Status

University General Hospital of Heraklion

Heraklio, , Greece

Site Status

University Hospital of Ioannina; Pulmonology Department

Ioannina, , Greece

Site Status

Hospital is University General Hospital of Larissa

Larissa, , Greece

Site Status

Athens Medical Center

Marousi, , Greece

Site Status

University General Hospital of Patras

Pátrai, , Greece

Site Status

"General hospital of Chest Diseases ""Sotiria"", 7th Pulmonary Clinic "

Sotiria Athens, , Greece

Site Status

General Hospital of Thessaloniki G. Papanikolaou

Thessaloniki, , Greece

Site Status

Prince of Wales Hospital; Dept. of Medicine & Therapeutics

Hong Kong, , Hong Kong

Site Status

The University of Hong Kong; Queen Mary Hospital

Hong Kong, , Hong Kong

Site Status

Semmelweis University

Budapest, , Hungary

Site Status

Debreceni Egyetem

Debrecen, , Hungary

Site Status

Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET

Szombathely, , Hungary

Site Status

Szent Borbala Korhaz

Tatabánya, , Hungary

Site Status

Tudogyogyintezet Torokbalint; Onkologiai és Jarobeteg Centrum

Törökbálint, , Hungary

Site Status

Barzilai Medical Center; Neurology Department

Ashkelon, , Israel

Site Status

Ben-Gurion University of the Negev - Soroka University Medical Center - Pulmonology Institute

Beersheba, , Israel

Site Status

Shamir medical center

Be’er Ya‘aqov, , Israel

Site Status

Rambam Health Care Campus

Haifa, , Israel

Site Status

Bnai Zion Medical Center; Internal Medicine

Haifa, , Israel

Site Status

Carmel Medical Center; Obstetrics and Gynecology

Haifa, , Israel

Site Status

Edith Wolfson Medical Center

Holon, , Israel

Site Status

Shaare Zedek Medical Center; Nrphrology Dept.

Jerusalem, , Israel

Site Status

Hadassah Medical Center

Jerusalem, , Israel

Site Status

Meir Medical Center

Kfar Saba, , Israel

Site Status

Rabin Medical Center

Petach Tiqwa, , Israel

Site Status

The Chaim Sheba Medical Center

Ramat Gan, , Israel

Site Status

Kaplan Medical Center

Rehovot, , Israel

Site Status

Tel-Aviv Sourasky Medical Center; Department of Pulmonary

Tel Aviv, , Israel

Site Status

Azienda Ospedaliera Papa Giovanni XXIII

Bergamo, Abruzzo, Italy

Site Status

Policlinico Riuniti di Foggia - Department of Medical and Surgical Sciences - University of Foggia

Foggia, Apulia, Italy

Site Status

Ospedale di Ostuni - Pneumologia

Ostuni, Apulia, Italy

Site Status

AORN Ospedali dei Colli Ospedale Monaldi; UOC Pneumologia ad indirizzo Oncologico

Napoli, Campania, Italy

Site Status

Azienda Ospedaliera Dei Colli

Napoli, Campania, Italy

Site Status

Azienda Ospedaliera Universitaria Federico II

Napoli, Campania, Italy

Site Status

Università degli Studi di Napoli Federico II; Dipartimento di Scienze Oftalmologiche

Napoli, Campania, Italy

Site Status

Ospedale Morgagni Pierantoni; Patologia clinica

Forlì, Emilia-Romagna, Italy

Site Status

A.O.U. Policlinico di Modena

Modena, Emilia-Romagna, Italy

Site Status

Azienda Sanitaria Universitaria Integrata di Trieste

Trieste, Friuli Venezia Giulia, Italy

Site Status

Policlinico Tor Vergata - U.O.C. Malattie Apparato Respiratorio

Rome, Lazio, Italy

Site Status

Fondazione Policlinico Universitario A Gemelli; Servizio di Farmacia

Rome, Lazio, Italy

Site Status

"Asst Rhodense - Unità operativa di pneumologia Ospedale ""Guido Salvini"" "

Garbagnate Milanese, Lombardy, Italy

Site Status

Ospedale San Giuseppe; U.O. di Pneumologia

Milan, Lombardy, Italy

Site Status

Asst Santi Paolo E Carlo

Milan, Lombardy, Italy

Site Status

Ospedale San Gerardo

Monza, Lombardy, Italy

Site Status

Fondazione IRCCS Policlinico San Matteo Divisione di EmatologiaDipartimento di Onco-Ematologia

Pavia, Lombardy, Italy

Site Status

A.O.U. S. Luigi Gonzaga; Interstiziopatie Malattie Rare Polmone

Orbassano (TO), Piedmont, Italy

Site Status

Azienda Ospedaliera Universitaria Citta della Salute e della Scienza di Torino; Ospedale Molinette

Turin, Piedmont, Italy

Site Status

A.O.U. Sassari; Dip. Medicina Clinica e Sperimentale

Sassari, Sardinia, Italy

Site Status

Azienda Ospedaliero - Universitaria Policlinico - Vittorio Emanuele

Catania, Sicily, Italy

Site Status

Az. Osp. Univ. P. Giaccone; UOC di Pneumologia

Palermo, Sicily, Italy

Site Status

Ismett Istituto Mediterraneo Trapianti E Terapie Alta Specializzazione;Pneumologia

Palermo, Sicily, Italy

Site Status

Azienda Ospedaliero Universitaria Ospedali Riuniti

Torrette Di Ancona, The Marches, Italy

Site Status

AOUC Azienda Ospedaliero-Universitaria Careggi; Neurologia 2

Florence, Tuscany, Italy

Site Status

A.O. Univ. Senese Policlinico S. Maria alle Scotte; Dip. Medicina clinica e Scienze Immunologiche

Siena, Tuscany, Italy

Site Status

Azienda Ospedale Università Di Padova; Clinica Pneumologica

Padua, Veneto, Italy

Site Status

University of Padova Ca' Foncello Hospital Immunologic & Respiratory Rare Diseases Center

Treviso, Veneto, Italy

Site Status

Nagoya University Hospital

Aichi, , Japan

Site Status

Chiba University Hospital

Chiba, , Japan

Site Status

National Hospital Organization Kyushu Medical Center

Fukuoka, , Japan

Site Status

Fukuoka University Hospital

Fukuoka, , Japan

Site Status

Kobe City Medical Center General Hospital

Hyōgo, , Japan

Site Status

National Hospital Organization Himeji Medical Center

Hyōgo, , Japan

Site Status

Kameda Medical Center

Kamogawa, , Japan

Site Status

Kanagawa Cardiovascular and Respiratory Center

Kanagawa, , Japan

Site Status

Nippon Medical School Musashi Kosugi Hospital

Kawasaki-Shi, , Japan

Site Status

Saiseikai Kumamoto Hospital

Kumamoto, , Japan

Site Status

Nagasaki University Hospital

Nagasaki, , Japan

Site Status

National Hospital Organization Ibarakihigashi National Hospital; Center for Clinical Research

Naka-gun, , Japan

Site Status

Kurashiki Central Hospital

Okayama, , Japan

Site Status

National Hospital Organization Kinki-Chuo Chest Medical Center

Sakaishi, , Japan

Site Status

Tosei General Hospital

Seto-shi, , Japan

Site Status

Tenri Hospital

Tenri-Shi, , Japan

Site Status

Jichi Medical University Hospital

Tochigi, , Japan

Site Status

Tokushima University Hospital

Tokushima, , Japan

Site Status

Tokyo Medical Ando Dentaluni Hospital Faculty of Medicine; Surgical Oncology

Tokyo, , Japan

Site Status

Center Hospital of the National Center for Global Health and Medicine

Tokyo, , Japan

Site Status

INER- Instituto Nacional de Enfermedades Respiratorias"Ismae

Mexico City, Mexico CITY (federal District), Mexico

Site Status

Centro Respiratorio de México

México, Mexico CITY (federal District), Mexico

Site Status

Unidad Médica para la Salud Integral UMSI

San Nicolás de los Garza, Nuevo León, Mexico

Site Status

Unidad de Investigacion CIMA SC

Chihuahua City, , Mexico

Site Status

CICC Morelia

Morelia, , Mexico

Site Status

VU Medisch Centrum

Amsterdam, , Netherlands

Site Status

Sint Antonius Ziekenhuis, locatie Nieuwegein

Nieuwegein, , Netherlands

Site Status

Erasmus Medisch Centrum

Rotterdam, , Netherlands

Site Status

Auckland City Hospital

Auckland, , New Zealand

Site Status

NZ Respiratory & Sleep Institute

Auckland, , New Zealand

Site Status

University of Otago, Christchurch

Christchurch, , New Zealand

Site Status

Waikato Hospital; Gastro Research

Hamilton, , New Zealand

Site Status

Tauranga Hospital

Tauranga, , New Zealand

Site Status

Helse Bergen HF Haukeland universitetssykehus

Bergen, , Norway

Site Status

Akershus universitetssykehus

Lørenskog, , Norway

Site Status

Oslo University Hospital HF, Rikshospitalet

Oslo, , Norway

Site Status

Centrum Medycyny Oddechowej Mroz sp. j.

Bia?ystok, , Poland

Site Status

Nasz Lekarz Osrodek Badan Klinicznych

Bydgoszcz, , Poland

Site Status

Uniwersytecki Szpital Kliniczny Nr 1 im.N.Barlickiego Oddzial Kliniczny Pneumonologii i Alergologii

Lodz, , Poland

Site Status

Hospital de Braga; Centro Clínico Académico (Piso 1, Ala E)

Braga, , Portugal

Site Status

Centro Hospitalar Algarve

Faro, , Portugal

Site Status

Hospital Senhora da Oliveira ? Guimarães, E.P.E

Guimarães, , Portugal

Site Status

Centro Hospitalar Universitario Lisboa Norte - Hospital Pulido Valente

Lisbon, , Portugal

Site Status

Centro Hospitalar do Porto - Hospital de Santo António

Porto, , Portugal

Site Status

Hospital de Sao Joao; Centro de Investigacao

Porto, , Portugal

Site Status

Hospital de Santa Luzia

Porto, , Portugal

Site Status

CHVNG/E_Unidade 1; Servico de Pneumologia

Vila Nova de Gaia, , Portugal

Site Status

Singapore General Hospital

Singapore, , Singapore

Site Status

Tan Tock Seng Hospital; Oncology

Singapore, , Singapore

Site Status

University of Cape Town Lung Institute; Lung Clinical Research

Cape Town, , South Africa

Site Status

Vergelegen Medi-Clinic

Somerset West, , South Africa

Site Status

Soon Chun Hyang University Hospital Bucheon

Bucheon-si, , South Korea

Site Status

The Catholic University of Korea Bucheon St. Mary's Hospital

Gyeonggi-do, , South Korea

Site Status

Gacheon University Gil Medical Center

Namdong-gu, , South Korea

Site Status

Seoul National University Bundang Hospital

Seongnam-si, , South Korea

Site Status

The Catholic University of Korea Yeouido St. Mary's Hospital; Hematology-Oncology

Seoul, , South Korea

Site Status

Seoul National University Hospital (SNUH) - Medical Oncology Center

Seoul, , South Korea

Site Status

Soonchunhyang University Hospital

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Korea University Guro Hospital

Seoul, , South Korea

Site Status

The Catholic University of Korea Seoul St. Mary?s Hospital

Seoul, , South Korea

Site Status

Hospital Txagorritxu

Vitoria-Gasteiz, Alava, Spain

Site Status

Hospital Universitario de Bellvitge

L'Hospitalet de Llobregat, Barcelona, Spain

Site Status

Parc Taulí Sabadell Hospital Universitari

Sabadell, Barcelona, Spain

Site Status

Hospital Universitario Marques de Valdecilla

Santander, Cantabria, Spain

Site Status

Complexo Hospitalario Universitario de Santiago (CHUS) - Hospital Clinico Universitario

Santiago de Compostela, LA Coruña, Spain

Site Status

Hospital Universitario del Henares

Coslada, Madrid, Spain

Site Status

Hospital Universitario Puerta de Hierro - Majadahonda

Majadahonda, Madrid, Spain

Site Status

Hospital Universitario Quironsalud Madrid

Pozuelo de Alarcón, Madrid, Spain

Site Status

Universidad de Navarra - Clinica Universitaria de Navarra (CUN)

Pamplona, Navarre, Spain

Site Status

Hospital Universitario Central de Asturias

Oviedo, Principality of Asturias, Spain

Site Status

Hospital Universitario de Canarias

S. Cristobal de La Laguna, Tenerife, Spain

Site Status

Hospital Galdakao-Usansolo

Galdakao, Vizcaya, Spain

Site Status

Hospital de la Santa Creu i Sant Pau; Servicio de Neumologia

Barcelona, , Spain

Site Status

Vall d?Hebron Institute of Oncology (VHIO), Barcelona

Barcelona, , Spain

Site Status

Hospital Clinic de Barcelona

Barcelona, , Spain

Site Status

Hospital Germans Trias i Pujol

Barcelona, , Spain

Site Status

Hospital Virgen de las Nieves; Servicio de Neumologia

Granada, , Spain

Site Status

Hospital Universitario de La Princesa

Madrid, , Spain

Site Status

Hospital Universitario La Paz

Madrid, , Spain

Site Status

Clínica Universidad de Navarra ? Madrid

Madrid, , Spain

Site Status

Hospital Ramón y Cajal;Servicio de Neumología

Madrid, , Spain

Site Status

Hosp. Clinico San Carlos

Madrid, , Spain

Site Status

Hospital Universitario Fundacion Jimenez Diaz.

Madrid, , Spain

Site Status

Hospital Universitario 12 de Octubre

Madrid, , Spain

Site Status

Hospital Clinico Universitario Virgen de la Victoria

Málaga, , Spain

Site Status

Hospital Clinico Universitario de Salamanca

Salamanca, , Spain

Site Status

Hospital Universitario Virgen del Rocio

Seville, , Spain

Site Status

Hospital Clinico Universitario de Valencia

Valencia, , Spain

Site Status

Hospital Arnau de Vilanova (Valencia)

Valencia, , Spain

Site Status

Hospital Universitari i Politecnic La Fe de Valencia

Valencia, , Spain

Site Status

Skånes universitetssjukhus Malmö

Malmo, , Sweden

Site Status

Inselspital Bern Universitätsklinik für Pneumologie

Bern, , Switzerland

Site Status

Hopital Neuchatelois Pourtales (Hopitaux Cadolles Pourtales)

Neuchâtel, , Switzerland

Site Status

Buddhist Tzu Chi Dalin General Hospital; Rheumatology

Chiayi City, , Taiwan

Site Status

Kaohsiung Medical University Hospital; Chung-Ho Memorial Hospital

Kaoshiung City, , Taiwan

Site Status

China Medical University Hospital

Taichung, , Taiwan

Site Status

National Cheng Kung University Hospital

Tainan City, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Far Eastern Memorial Hospital; Department of Clinical Pathology

Taipei, , Taiwan

Site Status

Veterans General Hospital - Taichung

Xitun Dist., , Taiwan

Site Status

Istanbul Universitesi Onkoloji Enstitüsü Hastanesi

?stanbul, , Turkey (Türkiye)

Site Status

Cukurova Universitesi Tip Fakultesi Balcali Hastanesi; Balcali

Adana, , Turkey (Türkiye)

Site Status

Ankara Universitesi Tip Fakultesi Hastaneleri - Cebeci Hastanesi

Ankara, , Turkey (Türkiye)

Site Status

Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi

Bursa, , Turkey (Türkiye)

Site Status

Gaziantep Universitesi - Sahinbey Arastirma ve Uygulama Hastanesi

Gaziantep, , Turkey (Türkiye)

Site Status

Yedikule Gogus Hastaliklari ve Gogus Cerrahisi EAH;Gogus Hastaliklari

Istanbul, , Turkey (Türkiye)

Site Status

Ege Universitesi Tip Fakultesi Hastanesi

Izmir, , Turkey (Türkiye)

Site Status

Dokuz Eylul University Faculty of Medicine; Chest Diseases

Izmir, , Turkey (Türkiye)

Site Status

Erciyes Üniversitesi T?p Fakültesi

Kayseri, , Turkey (Türkiye)

Site Status

Kocaeli Universitesi Tip Fakultesi

Kocaeli, , Turkey (Türkiye)

Site Status

Marmara Universitesi Hastanesi Marmara University Hospital

Maltepe, , Turkey (Türkiye)

Site Status

Mersin Üniversitesi Tip Fakültesi

Mersin, , Turkey (Türkiye)

Site Status

Akdeniz University Faculty of Medicine Department of Pulmonology

Muratpasa/Antalya, , Turkey (Türkiye)

Site Status

Koc Universitesi (KU) Tip Fakultesi (Koc University School of Medicine)

Sarıyer, , Turkey (Türkiye)

Site Status

Municipal Non-Profit Enterprise City Clinical Hospital #16 of Dnipro City Council

Dnipro, Katerynoslav Governorate, Ukraine

Site Status

National Academy of Medical Science of Ukraine (NAMS); NRCRM

Kyiv, KIEV Governorate, Ukraine

Site Status

Yanovskyy Inst of Phth. & Pulm; Clinical-functional

Kyiv, , Ukraine

Site Status

Edinburgh Royal Infirmary; Respiratory Department

Edinburgh, , United Kingdom

Site Status

Royal Brompton Hospital; Respiratory Department

London, , United Kingdom

Site Status

Manchester University NHS Foundation Trust - Wythenshawe Hospital

Manchester, , United Kingdom

Site Status

North Manchester General Hospital

Manchester, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Austria Belgium Brazil Canada China Czechia Denmark Finland France Germany Greece Hong Kong Hungary Israel Italy Japan Mexico Netherlands New Zealand Norway Poland Portugal Singapore South Africa South Korea Spain Sweden Switzerland Taiwan Turkey (Türkiye) Ukraine United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Cong M, Carvalho Gontijo Weber R, Sakane S, Zhang V, Jiang C, Taura K, Kodama Y, DeMinicis S, Ganguly S, Brafman D, Chien S, Kramer M, Lupher M, Brenner DA, Xu J, Kisseleva T. Serum amyloid P (PTX2) attenuates hepatic fibrosis in mice by inhibiting the activation of fibrocytes and HSCs. Hepatol Commun. 2024 Oct 17;8(11):e0557. doi: 10.1097/HC9.0000000000000557. eCollection 2024 Nov 1.

Reference Type DERIVED
PMID: 39761005 (View on PubMed)

Richeldi L, Schiffman C, Behr J, Inoue Y, Corte TJ, Cottin V, Jenkins RG, Nathan SD, Raghu G, Walsh SLF, Jayia PK, Kamath N, Martinez FJ. Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial. Am J Respir Crit Care Med. 2024 May 1;209(9):1132-1140. doi: 10.1164/rccm.202401-0116OC.

Reference Type DERIVED
PMID: 38354066 (View on PubMed)

Mantovani A, Garlanda C. Humoral Innate Immunity and Acute-Phase Proteins. N Engl J Med. 2023 Feb 2;388(5):439-452. doi: 10.1056/NEJMra2206346. No abstract available.

Reference Type DERIVED
PMID: 36724330 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-000791-38

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

WA42293

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.